Aldosterone in Diabetic Nephropathy

Summary

Aldosterone in Diabetic Nephropathy is a clinical trial^[1].

Key Facts

• Aldosterone in Diabetic Nephropathy is in the country of Chile^[2].
• Aldosterone in Diabetic Nephropathy's instance of is recorded as clinical trial^[3].
• Aldosterone in Diabetic Nephropathy's start time is recorded as +2009-03-31T00:00:00Z^[4].
• Aldosterone in Diabetic Nephropathy's end time is recorded as +2009-12-31T00:00:00Z^[5].
• Aldosterone in Diabetic Nephropathy's main subject is recorded as hypoaldosteronism^[6].
• Aldosterone in Diabetic Nephropathy's number of participants is recorded as {'unit': '1', 'amount': '+160'}^[7].
• Aldosterone in Diabetic Nephropathy's title is recorded as Effect of Aldosterone Antagonism in the Reduction of Albuminuria and Diastolic Disfunction of Patients With Diabetic Nephropathy.^[8].
• Aldosterone in Diabetic Nephropathy's short name is recorded as ALDODN^[9].
• Aldosterone in Diabetic Nephropathy's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+30'}^[10].
• Aldosterone in Diabetic Nephropathy's ClinicalTrials.gov ID is recorded as NCT00870402^[11].
• Aldosterone in Diabetic Nephropathy's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+70'}^[12].
• Aldosterone in Diabetic Nephropathy's research intervention is recorded as Spironolactone^[13].
• Aldosterone in Diabetic Nephropathy's clinical trial phase is recorded as phase IV clinical trial^[14].
• Aldosterone in Diabetic Nephropathy's research subject recruitment status is recorded as Coronavirus^[15].
• Aldosterone in Diabetic Nephropathy's study type is recorded as interventional study^[16].